ArticleStem cell reviews and reports2026
Long-Term Safety and Efficacy of Systemic DT-DEC01 Cell Therapy in Non-Ambulatory Duchenne Muscular Dystrophy Patients: a 24-Month Clinical Evaluation.
Maria Siemionow et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.